Pierre Bady

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

Pierre Bady, Davide Sciuscio, Annie-Claire Diserens et al. · Acta Neuropathologica · 2012 · 347 citations · Full text

Invertebrate traits for the biomonitoring of large European rivers: an initial assessment of alternative metrics

S. Gayraud, Bernhard Statzner, Pierre Bady et al. · Freshwater Biology · 2003 · 265 citations

Landscape Processes, Alternative Metrics, Biodiversity +14

Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Monika E. Hegi, Annie‐Claire Diserens, Pierre Bady et al. · Molecular Cancer Therapeutics · 2011 · 189 citations · Full text

Tumor Innervation, Chemoprevention Strategy, Pathology +20

Use of invertebrate traits for the biomonitoring of European large rivers: the effects of sampling effort on genus richness and functional diversity

Pierre Bady, Sylvain Dolédec, Christian Fesl et al. · Freshwater Biology · 2004 · 162 citations · Full text

Benthic Community, Biodiversity, Genus Richness +12

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without <i>MGMT</i> Promoter Hypermethylation (EORTC 26082)

Wolfgang Wick, Thierry Gorlia, Pierre Bady et al. · Clinical Cancer Research · 2016 · 152 citations · Full text